Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.2400
+0.0100 (4.35%)
May 22, 2026, 2:00 PM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 63.44 million as of May 22, 2026. Its market cap has increased by 44.53% in one year.
Market Cap
63.44M
Enterprise Value
63.71M
Revenue
816.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 63.44M, an increase of 661.78%. That is a compound annual growth rate of 6.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 63.44M | 45.13% |
| Dec 31, 2025 | 43.71M | -33.43% |
| Dec 31, 2024 | 65.66M | 64.23% |
| Dec 28, 2023 | 39.98M | -42.29% |
| Dec 30, 2022 | 69.28M | -9.56% |
| Dec 31, 2021 | 76.60M | 97.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 347.02M |
| Vector Science and Therapeutics | 186.98M |
| Cannabix Technologies | 81.08M |
| Perimeter Medical Imaging AI | 49.23M |
| Cheelcare | 35.60M |
| Conavi Medical | 27.94M |
| Ventripoint Diagnostics | 27.21M |
| Aurora Spine | 18.59M |